Hiroto Hatabu

Active 1995–2025

167
Papers
19,750
Citations
85
h-index
160
i10-index

Citations

Citations per year for Hiroto Hatabu1990: 1 citations1996: 4 citations1997: 4 citations1998: 16 citations1999: 50 citations2000: 25 citations2001: 35 citations2002: 31 citations2003: 28 citations2004: 40 citations2005: 17 citations2006: 44 citations2007: 47 citations2008: 42 citations2009: 39 citations2010: 60 citations2011: 54 citations2012: 86 citations2013: 94 citations2014: 88 citations2015: 99 citations2016: 134 citations2017: 162 citations2018: 190 citations2019: 563 citations2020: 767 citations2021: 805 citations2022: 744 citations2023: 557 citations2024: 758 citations2025: 337 citations2026: 15 citations1991–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,615 citing papers, 24.7% of this breakdownChina: 770 citing papers, 11.8% of this breakdownUnited Kingdom: 441 citing papers, 6.7% of this breakdownJapan: 376 citing papers, 5.7% of this breakdownGermany: 350 citing papers, 5.4% of this breakdownItaly: 308 citing papers, 4.7% of this breakdownFrance: 281 citing papers, 4.3% of this breakdownCanada: 242 citing papers, 3.7% of this breakdownSouth Korea: 207 citing papers, 3.2% of this breakdownNetherlands: 180 citing papers, 2.8% of this breakdownSpain: 178 citing papers, 2.7% of this breakdownAustralia: 132 citing papers, 2% of this breakdown
0%24.7%Other 22.3%

Fields

  • Medicine81.5%
  • Biochemistry, Genetics and Molecular Biology5.4%
  • Physics and Astronomy5.3%
  • Immunology and Microbiology2.5%
  • Engineering2%
  • Computer Science1.6%
  • Other1.7%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis8.3%
  • Cancer Immunotherapy and Biomarkers7.7%
  • Lung Cancer Diagnosis and Treatment4.4%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.3%
  • Radiomics and Machine Learning in Medical Imaging3.2%
  • Lung Cancer Treatments and Mutations3.2%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Monitoring immune-checkpoint blockade: response evaluation and biomarker development

    Authors: , , , - Nature Reviews Clinical Oncology 2017 cited by 1,086

  2. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 cited by 570

  3. Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

    Authors: , , , , - JAMA Oncology 2016 cited by 755

  4. Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 615

  5. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ayodeji Adegunsoye, Mary E. Strek, Margaret Neighbors, Xuting R. Sheng, Gunnar Guðmundsson, Vilmundur Guðnason, Hiroto Hatabu, David J. Lederer, Ani Manichaikul, John D. Newell, George O'connor, Victor E. Ortega, Hanfei Xu, Tasha E. Fingerlin, Yohan Bossé, Ke Hao, Philippe Joubert, David C. Nickle, Don D. Sin, Wim Timens, Dominic Furniss, Andrew P. Morris, Krina T. Zondervan, Ian P. Hall, Ian Sayers, Martin D. Tobin, Toby M. Maher, Michael H. Cho, Gary M. Hunninghake, David A. Schwartz, Brian L. Yaspan, Philip L. Molyneaux, Carlos Flores, Imre Noth, Gísli Jenkins, Louise V. Wain - American Journal of Respiratory and Critical Care Medicine 2019 cited by 341

  6. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 cited by 228

  7. Association Between Interstitial Lung Abnormalities and All-Cause Mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher J. O’Donnell, Lenore J. Launer, Tamara B. Harrris, Vilmundur Guðnason, Edwin K. Silverman, George O'connor, George R. Washko, Iván O. Rosas, Gary M. Hunninghake, for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) and COPDGene Investigators - JAMA 2016 cited by 465

  8. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 258

  9. Detection of Rheumatoid Arthritis–Interstitial Lung Disease Is Enhanced by Serum Biomarkers

    Authors: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 cited by 216

  10. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , , - The Journal of Rheumatology 2020 cited by 109

  11. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study

    Authors: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 cited by 352

  12. Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society

    Authors: , , , , , , , , , , , , , , , , , , , , , - Radiology 2021 cited by 116

  13. PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course

    Authors: , , , , , , , , , - Clinical Cancer Research 2016 cited by 494

  14. Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis

    Authors: , , , , , , - Radiology 2020 cited by 168

  15. Interstitial Lung Abnormalities: State of the Art

    Authors: , , , - Radiology 2021 cited by 152

  16. Commonly Missed Findings on Chest Radiographs

    Authors: , , - CHEST Journal 2022 cited by 71

  17. MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 448

  18. Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper

    Authors: , , , , , , , , , , , , , , - Radiology 2020 cited by 184

  19. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , - CHEST Journal 2021 cited by 128

  20. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 104

  21. The Proteomic Profile of Interstitial Lung Abnormalities

    Authors: , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 49

  22. Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy

    Authors: , , , , - New England Journal of Medicine 2015 cited by 374

  23. Identification of Early Interstitial Lung Disease in Smokers from the COPDGene Study

    Authors: , , , , , , , , , , , - Academic Radiology 2009 cited by 233

  24. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management

    Authors: , , , , , , , , , - European Journal of Radiology Open 2022 cited by 81